Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

136 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial.
Rinnerthaler G, Egle D, Bartsch R, Schmitt CA, Petzer A, Balic M, Petru E, Denison U, Singer CF, Bjelic-Radisic V, Gampenrieder SP, Knauer M, Sotlar K, Brunner C, Posch F, Hlauschek D, Sölkner L, Bago-Horvath Z, Filipits M, Gili M, Ritter M, Wieser V, Albertini C, Zaborsky N, Weiss L, Marhold M, Schneeweiss B, Pusch R, Gnant M, Greil R. Rinnerthaler G, et al. Among authors: posch f. Nat Cancer. 2025 Jan 16. doi: 10.1038/s43018-024-00890-2. Online ahead of print. Nat Cancer. 2025. PMID: 39820125
Comparative efficacy and safety of treatment regimens for Pneumocystis jirovecii pneumonia in people living with HIV: a systematic review and network meta-analysis of randomized controlled trials.
Hatzl S, Posch F, Scholz L, Geiger C, Kriegl L, Kreuzer P, Eller P, Giacobbe DR, Bassetti M, Hoenigl M, Krause R. Hatzl S, et al. Among authors: posch f. Clin Microbiol Infect. 2024 Dec 26:S1198-743X(24)00612-8. doi: 10.1016/j.cmi.2024.12.024. Online ahead of print. Clin Microbiol Infect. 2024. PMID: 39732393 Free article. Review.
Prognostic impact of targetable driver alterations in resected early-stage lung cancer.
Terbuch A, Konjic S, Schlintl V, Absenger G, Jost PJ, Lindenmann J, Swatek P, John N, John T, Wurm R, Zacharias M, Posch F, Hochmair MJ, Fabikan H, Weinlinger C, Illini O, Horvath L, Gamerith G, Wolf D, Augustin F, Brcic L. Terbuch A, et al. Among authors: posch f. Transl Lung Cancer Res. 2024 Nov 30;13(11):3096-3105. doi: 10.21037/tlcr-24-433. Epub 2024 Nov 14. Transl Lung Cancer Res. 2024. PMID: 39670019 Free PMC article.
Lipoprotein (a) is not associated with thrombus burden derived from CT pulmonary angiography in patients with acute pulmonary embolism.
Gressenberger P, Posch F, Adelsmayr G, Nagy E, Kaufmann-Bühler AK, Steiner J, Janisch M, Reiter C, Eibisberger M, Janek E, Softic N, Fuchsjäger M, Gütl K, Jud P, Silbernagel G, Raggam RB, Brodmann M, Gary T, Schmid J. Gressenberger P, et al. Among authors: posch f. Sci Rep. 2024 Oct 29;14(1):25962. doi: 10.1038/s41598-024-77669-z. Sci Rep. 2024. PMID: 39472600 Free PMC article.
Longitudinal analysis of PD-L1 expression in patients with relapsed NSCLC.
John N, Schlintl V, Sassmann T, Lindenmann J, Fediuk M, Wurm R, Douschan P, Zacharias M, Kalson L, Posch F, Absenger G, Brcic L, Jost PJ, Terbuch A. John N, et al. Among authors: posch f. J Immunother Cancer. 2024 Apr 11;12(4):e008592. doi: 10.1136/jitc-2023-008592. J Immunother Cancer. 2024. PMID: 38604811 Free PMC article.
Ruxolitinib, IV Immunoglobulin, and High-Dose Glucocorticoids for Critically Ill Adults With Secondary Hemophagocytic Lymphohistiocytosis: A Single-Center Observational Pilot Study.
Scholz L, Posch F, Schulz E, Gornicec M, Wölfler A, Reisinger AC, Reinisch A, Eller P, Eisner F, Kreuzer P, Stradner M, Rosenkranz AR, Krammer F, Schilcher G, Krause R, Hatzl S. Scholz L, et al. Among authors: posch f. Crit Care Explor. 2024 Feb 2;6(2):e1046. doi: 10.1097/CCE.0000000000001046. eCollection 2024 Feb. Crit Care Explor. 2024. PMID: 38511127 Free PMC article.
Early kinetics of C reactive protein for cancer-agnostic prediction of therapy response and mortality in patients treated with immune checkpoint inhibitors: a multicenter cohort study.
Barth DA, Moik F, Steinlechner S, Posch F, Mayer MC, Sandner AM, Berton F, Schlintl V, Koch L, John N, Wurm R, Pichler M, Bauernhofer T, Reimann P, Wohlkönig C, Richtig E, Winder T, Preusser M, Jost PJ, Ay C, Gerger A, Terbuch A, Riedl JM. Barth DA, et al. Among authors: posch f. J Immunother Cancer. 2023 Dec 14;11(12):e007765. doi: 10.1136/jitc-2023-007765. J Immunother Cancer. 2023. PMID: 38097343 Free PMC article.
136 results